BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang W, Deng ZF, Wang JL, Zhang L, Bao L, Xu BH, Zhu H, Guo Y, Wen Z. Change of tumor-infiltrating lymphocyte of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma. World J Gastrointest Surg 2022; 14(9): 1008-1025 [PMID: 36185571 DOI: 10.4240/wjgs.v14.i9.1008]
URL: https://www.wjgnet.com/1948-9366/full/v14/i9/1008.htm
Number Citing Articles
1
Lingzhen Hu, Zongren Wang, Yang Liao, Xiaomeng Jiang, Huojun Lian, Zhuoying Lin. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinomaOncology and Translational Medicine 2024; 10(4): 162 doi: 10.1097/ot9.0000000000000041
2
Victor Lopez-Lopez, Carlos Martínez-Caceres, Paula Gomez-Valles, Juan Cruz, Albert Caballero-Illanes, Roberto Brusadin, Asuncion López-Conesa, María Pérez, Kohei Miura, Jesús de la Peña-Moral, Ricardo Robles-Campos. Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastasesHPB 2023; 25(10): 1235 doi: 10.1016/j.hpb.2023.06.005